v3.23.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]    
Revenue from contract with customer, product and service Grant Grant
Grant revenue $ 0 $ 1,840,216
Operating expenses:    
Research and development 15,836,828 8,548,520
General and administrative 7,138,403 6,104,627
Loss on impairment of goodwill 8,865,909 0
Total operating expenses 31,841,140 14,653,147
Loss before other income (expense) (31,841,140) (12,812,931)
Change in fair value of warrant liability 14,454 44,693
Interest income 218,730
Net loss (31,607,956) (12,768,238)
Loss attributable to common stockholders $ (31,607,956) $ (12,768,238)
Loss per common share, basic (in dollars per share) $ (14.88) $ (7.72)
Loss per common share, diluted (in dollars per share) (14.88) (7.72)
Total net loss per share (in dollars per share) $ (14.88) $ (7.72)
Weighted average number of shares outstanding, basic (in shares) 2,124,511 1,654,638
Weighted average number of shares outstanding, diluted (in shares) 2,124,511 1,654,638